Condition
Cervicitis
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
Early P 1 (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05564299Not ApplicableCompleted
Rapid Diagnostic Assay for Gonorrhea and Chlamydia
NCT05675293Early Phase 1UnknownPrimary
Cervicitis by Iontophoresis
NCT04809727Not ApplicableCompleted
Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy
NCT01072136Phase 3Terminated
Empiric Therapy of Mucopurulent Cervicitis (MPC)
NCT01661985Phase 4Unknown
Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced
Showing all 5 trials